All In MedTech

Device Trial Radar · NCT03273907

Post Approval Study of the CyPass System

Post Approval Study of the CyPass System in Patients With Primary Open Angle Glaucoma Undergoing Cataract Surgery

Last checked: Nov 20, 2026Latest source record: Feb 16, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

79

Actual

Start

Oct 12, 2017

Primary completion

Aug 31, 2021

Study completion Aug 31, 2021

Sponsor

Lead sponsor
Alcon ResearchNot on our public-company list
Sponsor type
Industry
First posted
Sep 6, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 45 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to demonstrate that the rate of clinically relevant complications associated with CyPass Micro-Stent placement and stability using the CyPass 241-S applier, as determined at 36 months in the postmarket setting, is less than the pre-specified performance target, which is based on experience with the CyPass Model E applier in COMPASS trial TMI-09-01 (NCT01085357).

Conditions

  • Primary Open-angle Glaucoma
  • Cataract

Interventions

  • CyPass Micro-Stent implanted with CyPass 241-S applierDevice

    CyPass System (Model 241-S) consists of the CyPass Micro-Stent contained in a loading device (loader) and the CyPass applier.The CyPass Micro-Stent is an implantable medical device intended for long term use.

  • Cataract surgeryProcedure

    Cataract surgery, followed by implantation of the CyPass Micro-Stent in one eye (the study eye) at the surgery visit

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Eyes With Clinically Relevant Complications Associated With CyPass Micro-Stent Placement and Stability as Determined at Month 36Time frame: Up to Month 36 postoperative

Locations

20 sites in 1 country. Site status is shown where the registry gives one.

  • Alcon Investigative Site

    Phoenix, Arizona

  • Alcon Investigative Site

    Orange, California

  • Alcon Investigative Site

    Fort Collins, Colorado

17 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.